2016 Starts With A Splat, But Traders Thrive In A Volatile Market!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

We hope all of you had a safe and very happy holiday season. We certainly did, and were reminded (as we are every year) how thankful we are to be in a position to live our passion and trade the market daily; something we all take for granted on a daily basis.

The New Year rang in with a sea of red, as U.S. markets felt the pressure from overseas following China’s Shanghai composite falling -6.86% which was exacerbated by the use of newly installed circuit breakers meant to curb panic. Those never really work as planned, do they?

U.S. markets recovered, relatively speaking, with the NASDAQ and the most popular ETF in the U.S., the SPDR S&P 500 (SPY), which tracks the S&P index, closing at session highs.

While OTC Markets remained unfazed (as usual) by the drama unfolding abroad and here at home, certain names moved higher with increasing volume.

Today’s standouts included Medbox, Inc. (MDBX) and Sunshine Biopharma (SBFM), which have both been hot topics in our absence over the past week.

Medbox, Inc. (MDBX) has made some exciting announcements over the past couple weeks, first announcing they entered into a business agreement to create a large U.S. source of CBD oil, and then (more importantly) added last week that they had reached an agreement with one of their primary lending sources to put a temporary restriction on converting shares through next month.

Shares of Medbox closed up 55.77% today, with a noticeable increase in trading volume, as more than 17.5 million shares exchanged hands between .02-.0415, and finished at .0405.

Watch for a potential move to the 50 day moving average of .047, or a more psychological level such as .05, and if support starts to form above those levels and another strong close follows, a move to the next resistance range near .075 could be in the works.

Sunshine Biopharma (SBFM) has also made smooth moves in our absence, following the announcement last week that they acquired all remaining worldwide patents for its ‘Adva-27a’ anti-cancer compound, and is up nearly 1000% since as a result of said news.

While shares seem overbought at current prices, the stock has been accumulated on each dip over the past week, and buyers could seek to push it higher before it even thinks of going lower.

Ideally, we would like to see support at the 200 day moving average of .015, and a potential push past .02 (or higher) again for a trade idea.

Keep both Medbox, Inc. (MDBX) and Sunshine Biopharma (SBFM) on close watch tomorrow for continued moves higher.

Lets make 2016 another great year filled with profitable trades that make sense.

Happy Trading & Happy New Year!

Sign up-> NOW <-To Join Our E-mail List!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.